TORONTO, June 18, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that the Company has applied to list its common shares on the Toronto Stock Exchange (“TSX”). Listing
[Read More ...]
Originally posted on MediPharm Labs Announces Application to Upgrade Listing to the Toronto Stock Exchange via Vic Neufeld Medical Marijuana News
No comments:
Post a Comment